City

Clinical trials near Charlottesville, United States

Active studies with a listed research site in Charlottesville, United States.

15active studies

7recruiting now

14countries represented

140largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

This Study Will Evaluate Cardiorespiratory and Muscular Fitness to Examine Associations With Anthropometric Characteristics and Other Indicators of Cardiometabolic Risk Among Patients With or Without Autism Spectrum Disorder

Autism Spectrum Disorder (ASD), Cardiometabolic Health IndicatorsCondition

Intervention not listedTreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-09-04 · NCT07804680See eligibility →

Recruiting nowPhase 4

Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction

Heart Failure Preserved Ejection Fraction, Epicardial Adipose TissueCondition

GLP-1RATreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-08-11 · NCT07178145See eligibility →

Recruiting nowNot applicable

Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes

Type 1 Diabetes, OverweightCondition

Exercise trainingTreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-05-07 · NCT07573228See eligibility →

Recruiting nowPhase 2

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Obesity in Children, Bone StrengthCondition

GLP-1 receptor agonist, Lifestyle interventionTreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-04-17 · NCT06903923See eligibility →

Recruiting nowNot applicable

Examining Valence-based Effects in Self-Monitoring Feedback Messages

Obesity & Overweight, Obesity (Disorder)Condition

Positive Reinforcement, Positive Reinforcement + Areas for ChangeTreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-03-31 · NCT07292389See eligibility →

Recruiting nowNot applicable

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Type 2 Diabetes, Overweight and ObesityCondition

Cardiovascular exerciseTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-03-23 · NCT04791371See eligibility →

Recruiting nowNot applicable

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

Heart Failure, Systolic, Heart Failure, DiastolicCondition

Intervention not listedTreatment

United States1 locations

University of VirginiaSponsor

Updated 2025-12-24 · NCT06009276See eligibility →

Opening soonPhase 3

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Argentina, Brazil56 locations

Novo Nordisk A/SSponsor

Updated 2026-05-28 · NCT07282613See eligibility →

Opening soonPhase 3

The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

Obesity & OverweightCondition

Tirzepatide, ExerciseTreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-05-06 · NCT07298915See eligibility →

Active, not recruitingPhase 2

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

ObesityCondition

Trevogrumab-Part A, Trevogrumab-Part B and Part CTreatment

Puerto Rico, United States60 locations

Regeneron PharmaceuticalsSponsor

Updated 2026-09-01 · NCT06299098See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

ObesityCondition

Retatrutide, TirzepatideTreatment

Argentina, Germany65 locations

Eli Lilly and CompanySponsor

Updated 2026-07-20 · NCT06662383See eligibility →

Active, not recruitingNot applicable

Obesity and Pediatric Multiple Sclerosis

Multiple SclerosisCondition

Intervention not listedTreatment

United States2 locations

University of VirginiaSponsor

Updated 2026-04-29 · NCT04593082See eligibility →

Active, not recruitingPhase 4

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

ObesityCondition

Naltrexone-Bupropion (NB) Combination, PlaceboTreatment

United States140 locations

Currax PharmaceuticalsSponsor

Updated 2026-03-31 · NCT06098079See eligibility →

Active, not recruitingPhase 2

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Type 2 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Mexico40 locations

Eli Lilly and CompanySponsor

Updated 2026-03-23 · NCT06037252See eligibility →

Active, not recruitingPhase 2

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

ObesityCondition

Nimacimab injection, Nimacimab placebo injectionTreatment

United States16 locations

Skye Bioscience, Inc.Sponsor

Updated 2026-01-14 · NCT06577090See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Charlottesville, United States

Current studies

Related cities